Applications encouraged for NCI Outstanding Investigator Award; deadline tomorrow
Internal submissions due Sept. 28.
These instructions are for VUMC applicants only.
The National Cancer Institute has issued a funding opportunity announcement for the R35 Outstanding Investigator Award (OIA): PAR-18-880. Faculty with outstanding records of productivity in any area of cancer research are eligible. The OIA will support investigators with up to $600,000 in direct costs per year for 7 years to provide funding stability. The NCI requests a Letter of Intent by Oct. 3, and full applications are due Nov. 2.
- Program Director/Principal Investigator (PD/PI) with outstanding cancer research productivity during the last 5 consecutive calendar years.
- PD/PI must have been a PD/PI or Project Leader of a research project, excluding cores, on an eligible NCI research grant(s) continuously since September 2013. Eligible NCI research grant mechanisms are defined as R01, R15, R33, R37, P01, P50, U01, U54, UM1, U19, U10, DP1, and DP2.
- Applicants are required to devote at least 6 person months effort to the OIA. Applicants with administrative responsibilities or other duties inconsistent with this time commitment may apply but must reduce those other commitments to accept the award.
Internal Review and Institutional Letter of Nomination
All applications to the OIA must obtain an institutional letter of nomination. If you intend to apply to the NCI Outstanding Investigator Award program, please submit the following to Susan Meyn (email@example.com) by Sept. 28:
- Brief research plan (two-page maximum) including summary budget
- Copy of the Letter of Intent submitted to NCI (draft version acceptable)
- NIH Biosketch
- Brief letter of support from department chair. Should include “A clear and continuing substantial institutional commitment to the PD/PI beyond the normal level extended by the Institution to faculty, for example, providing 20 percent salary support for the duration of the award.
If you have any questions, you may contact Susan Meyn in the Office of Research.